Scientific Reports (Oct 2022)

Prevention of Shiga toxin 1-caused colon injury by plant-derived recombinant IgA

  • Katsuhiro Nakanishi,
  • Taichi Takase,
  • Yuya Ohira,
  • Ryota Ida,
  • Noriko Mogi,
  • Yuki Kikuchi,
  • Minami Matsuda,
  • Kohta Kurohane,
  • Yoshihiro Akimoto,
  • Junri Hayakawa,
  • Hayato Kawakami,
  • Yasuo Niwa,
  • Hirokazu Kobayashi,
  • Eiji Umemoto,
  • Yasuyuki Imai

DOI
https://doi.org/10.1038/s41598-022-22851-4
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Immunoglobulin A (IgA) is a candidate antibody for oral passive immunization against mucosal pathogens like Shiga toxin-producing Escherichia coli (STEC). We previously established a mouse IgG monoclonal antibody (mAb) neutralizing Shiga toxin 1 (Stx1), a bacterial toxin secreted by STEC. We designed cDNA encoding an anti-Stx1 antibody, in which variable regions were from the IgG mAb and all domains of the heavy chain constant region from a mouse IgA mAb. Considering oral administration, we expressed the cDNA in a plant expression system aiming at the production of enough IgA at low cost. The recombinant-IgA expressed in Arabidopsis thaliana formed the dimeric IgA, bound to the B subunit of Stx1, and neutralized Stx1 toxicity to Vero cells. Colon injury was examined by exposing BALB/c mice to Stx1 via the intrarectal route. Epithelial cell death, loss of crypt and goblet cells from the distal colon were observed by electron microscopy. A loss of secretory granules containing MUC2 mucin and activation of caspase-3 were observed by immunohistochemical methods. Pretreatment of Stx1 with the plant-based recombinant IgA completely suppressed caspase-3 activation and loss of secretory granules. The results indicate that a plant-based recombinant IgA prevented colon damage caused by Stx1 in vivo.